Author:
Biernacki Pamela,Kverno Karan
Abstract
Anxiety disorders are the most common mental illnesses and frequently co-occur with other mental and somatic symptoms or disorders. Primary care nurse practitioners (NPs) are key in reducing the treatment gap through early identification, treatment, and/or referral to behavioral health providers. Confronting primary care NPs are problems with time constraints, multiple comorbidities, and limited mental health training, particularly in relation to the differences in pharmacokinetic and pharmacodynamic actions of first-line anxiety disorder medications across age groups. The current article provides a brief summary of evidence-based treatment focusing on pharmacotherapy for anxiety disorders in the primary care setting. [
Journal of Psychosocial Nursing and Mental Health Services, 62
(5), 7–10.]
Reference24 articles.
1. American Academy of Pediatrics. (2024). Screening tools: Pediatric mental health minute series. https://www.aap.org/en/patient-care/mental-health-minute/screening-tools/
2. American Association of Nurse Practitioners. (2023). The most comprehensive data about nurse practitioners (NPs) and the NP role. https://www.aanp.org/practice/practice-related-research/research-reports
3. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults
4. Diagnostic and Statistical Manual of Mental Disorders
5. Anxiety and Depression Association of America. (2022). Anxiety disorders: Facts & statistics. https://adaa.org/understanding-anxiety/facts-statistics